183 related articles for article (PubMed ID: 19242540)
1. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.
Colombatti M; Grasso S; Porzia A; Fracasso G; Scupoli MT; Cingarlini S; Poffe O; Naim HY; Heine M; Tridente G; Mainiero F; Ramarli D
PLoS One; 2009; 4(2):e4608. PubMed ID: 19242540
[TBL] [Abstract][Full Text] [Related]
2. Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen.
Schmidt S; Gericke B; Fracasso G; Ramarli D; Colombatti M; Naim HY
PLoS One; 2013; 8(6):e66193. PubMed ID: 23840421
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
4. The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.
Ben Jemaa A; Sallami S; Ramarli D; Colombatti M; Oueslati R
Inflammation; 2013 Jun; 36(3):643-50. PubMed ID: 23250823
[TBL] [Abstract][Full Text] [Related]
5. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
Steiner H; Godoy-Tundidor S; Rogatsch H; Berger AP; Fuchs D; Comuzzi B; Bartsch G; Hobisch A; Culig Z
Am J Pathol; 2003 Feb; 162(2):655-63. PubMed ID: 12547723
[TBL] [Abstract][Full Text] [Related]
6. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases.
Amrani Y; Ammit AJ; Panettieri RA
Mol Pharmacol; 2001 Oct; 60(4):646-55. PubMed ID: 11562425
[TBL] [Abstract][Full Text] [Related]
8. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta.
Kim MO; Suh HS; Brosnan CF; Lee SC
J Neurochem; 2004 Jul; 90(2):297-308. PubMed ID: 15228586
[TBL] [Abstract][Full Text] [Related]
9. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.
Caromile LA; Dortche K; Rahman MM; Grant CL; Stoddard C; Ferrer FA; Shapiro LH
Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292957
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific membrane antigen (PSMA): a novel modulator of p38 for proliferation, migration, and survival in prostate cancer cells.
Zhang Y; Guo Z; Du T; Chen J; Wang W; Xu K; Lin T; Huang H
Prostate; 2013 Jun; 73(8):835-41. PubMed ID: 23255296
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".
Perico ME; Grasso S; Brunelli M; Martignoni G; Munari E; Moiso E; Fracasso G; Cestari T; Naim HY; Bronte V; Colombatti M; Ramarli D
Oncotarget; 2016 Nov; 7(45):74189-74202. PubMed ID: 27713116
[TBL] [Abstract][Full Text] [Related]
12. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.
Craig R; Larkin A; Mingo AM; Thuerauf DJ; Andrews C; McDonough PM; Glembotski CC
J Biol Chem; 2000 Aug; 275(31):23814-24. PubMed ID: 10781614
[TBL] [Abstract][Full Text] [Related]
13. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.
Fiebich BL; Schleicher S; Butcher RD; Craig A; Lieb K
J Immunol; 2000 Nov; 165(10):5606-11. PubMed ID: 11067916
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinases and nuclear factor-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages.
Bhattacharyya A; Pathak S; Datta S; Chattopadhyay S; Basu J; Kundu M
Biochem J; 2002 Nov; 368(Pt 1):121-9. PubMed ID: 12150710
[TBL] [Abstract][Full Text] [Related]
15. Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation.
Tsai CY; Lee TS; Kou YR; Wu YL
J Cell Biochem; 2009 Oct; 108(2):489-98. PubMed ID: 19626664
[TBL] [Abstract][Full Text] [Related]
16. c-myc Promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway.
Ghosh AK; Steele R; Ray RB
J Biol Chem; 2005 Apr; 280(14):14325-30. PubMed ID: 15805119
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
Birkenkamp KU; Esselink MT; Kruijer W; Vellenga E
Eur Cytokine Netw; 1999 Dec; 10(4):479-90. PubMed ID: 10586114
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
Hobisch A; Eder IE; Putz T; Horninger W; Bartsch G; Klocker H; Culig Z
Cancer Res; 1998 Oct; 58(20):4640-5. PubMed ID: 9788616
[TBL] [Abstract][Full Text] [Related]
19. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
Bawazeer MA; Theoharides TC
Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
